A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.

Published by Michael on

Related Posts

Medical

Efficacy of cannabis and its constituents in disease management: Insights from clinical studies

Curr Med Chem. 2022 May 25. doi: 10.2174/0929867329666220525124818. Online ahead of print. ABSTRACT There is a long history of informal use of Cannabis sativa (commonly called cannabis) for many purposes, including treating various ailments worldwide. Read more…

Medical

Altered White Matter Integrity at Illness Onset in Adolescents With a First Episode of Psychosis

Front Psychiatry. 2022 May 10;13:876793. doi: 10.3389/fpsyt.2022.876793. eCollection 2022. ABSTRACT BACKGROUND: Disruption in white matter integrity has been consistently observed in individuals with psychosis. However, whether such abnormalities are already present at illness onset or Read more…

Medical

Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years

Front Pharmacol. 2022 May 10;13:885655. doi: 10.3389/fphar.2022.885655. eCollection 2022. ABSTRACT A regulatory framework allowing legal access to medicinal cannabis (MC) products has operated in Australia since November 2016. MC prescribing by healthcare practitioners (HCPs) is Read more…

error: Content is protected !!